Introduction
The Halene Laboratory focuses on the study of myeloid malignancies and hematopoiesis. In particular we seek to understand the role of mutations in splicing factors, present in nearly 50% of patient with Myelodysplasia (MDS) and Acute Myeloid Leukemia (AML). In addition, we seek to establish a “co-clinical” model for MDS and AML with the goal to facilitate the translation of improved, less toxic, and more efficient treatments for MDS and AML into the clinic.
Twitter Feed
@Halene_lab Retweeted @YaleCancerCongratulations to Dr. Stephanie Halene @Halene_lab and Dr. Jeffrey Ishizuka @ishizukalab on their grant from the Edward P. Evans Foundation to research and advance treatments for myelodysplastic syndromes. @SmilowCancer @YaleMed @YNHH #MDS #blooddisorders @YaleHematology https://t.co/JdDUJ2thPeA MONTH AGO
@Halene_lab Retweeted @jennkwanMDPhDLook forward to representing @YaleCardiology & sharing work on Clonal Hematopoiesis of Indeterminate Potential (#CHIP) in #cardiooncology patients & its effects on myocardial function #bioengineering #genetics #imaging #immunology @Halene_lab @YaleMed https://t.co/RWcJnJxBVxA MONTH AGO
@Halene_lab Retweeted @YaleCCEHJoin us tomorrow morning at 9:30am when we continue our summer computational didactic series. Dr. Toma Tebaldi (from the @Halene_lab) will present the second half of his talk on analysis and interpretation of single cell sequencing data.A MONTH AGO
Principal Investigator
Stephanie Halene, MD, PhD
Associate Professor of Medicine (Hematology)
Contact Information
- Office
- Fax
- Appt